• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    United Therapeutics Corporation - Common Stock (NQ:UTHR)

    479.79 +1.52 (+0.32%)
    Streaming Delayed Price Updated: 11:57 AM EST, Feb 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 248,999
    Open 481.97
    Bid (Size) 478.29 (40)
    Ask (Size) 481.28 (40)
    Prev. Close 478.27
    Today's Range 472.51 - 487.50
    52wk Range 266.98 - 519.99
    Shares Outstanding 44,891,523
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    A Look Back at Therapeutics Stocks’ Q3 Earnings: United Therapeutics (NASDAQ:UTHR) Vs The Rest Of The Pack
    The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q3, starting with United... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    $100 Million Exit: Why One Fund Walked Away From a Chinese E-Commerce Stock Up 24% ↗
    Vipshop Holdings is a major Chinese e-commerce retailer specializing in branded discount sales for value-focused consumers. 
    Via The Motley Fool
    Topics Economy

    Performance

    YTD
    -3.4%
    -3.4%
    1 Month
    -2.0%
    -2.0%
    3 Month
    +9.7%
    +9.7%
    6 Month
    +57.4%
    +57.4%
    1 Year
    +35.3%
    +35.3%

    More News

    Read More
    News headline image
    This Bank Stock Just Saw a $24 Million Fund Sale, but Here's Why It's Still a Top Holding ↗
    Via The Motley Fool
    Topics Credit Cards ETFs
    News headline image
    Therapeutics Stocks Q3 Highlights: United Therapeutics (NASDAQ:UTHR)
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP® in Patients with Acute Liver Failure
    From United Therapeutics Corporation
    Via Business Wire
    News headline image
    United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
    From United Therapeutics Corporation
    Via Business Wire
    News headline image
    3 Market-Beating Stocks to Target This Week
    Via StockStory
    Topics Credit Cards Supply Chain
    News headline image
    Investment Advisor Doubles Down on Insurance Stock, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Bonds Regulatory Compliance
    News headline image
    Nepsis Bets on CAVA's Future Growth Plan With $2.9 Million Purchase ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    2 Cash-Heavy Stocks to Target This Week and 1 We Question
    Via StockStory
    News headline image
    United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
    From United Therapeutics Corporation
    Via Business Wire
    News headline image
    Therapeutics Stocks Q3 In Review: Biogen (NASDAQ:BIIB) Vs Peers
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why a $27 Million Buy Signals New Confidence in Weatherford Stock ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Signet Jewelers Gains New $25 Million Institutional Backer — Is the Stock a Buy? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why a Value Fund Has a $29 Million Bet on Core Natural Resources Stock ↗
    Via The Motley Fool
    Topics Regulatory Compliance Supply Chain
    News headline image
    Is Kulicke and Soffa Stock a Buy Even as One Fund Dumps a $10 Million Stake? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    United Therapeutics Corp (NASDAQ:UTHR): A Value Investing Case Study ↗
    Via Chartmill
    News headline image
    United Therapeutics Corp (NASDAQ:UTHR): A Caviar Cruise Quality Investment ↗
    Via Chartmill
    News headline image
    2 Mooning Stocks on Our Buy List and 1 That Underwhelm
    Via StockStory
    News headline image
    Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today ↗
    Via Benzinga
    News headline image
    United Therapeutics Corp (NASDAQ:UTHR) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    News headline image
    3 Reasons Investors Love United Therapeutics (UTHR)
    Via StockStory
    News headline image
    Is United Therapeutics Corp Gaining or Losing Market Support? ↗
    Via Benzinga
    News headline image
    P/E Ratio Insights for United Therapeutics ↗
    Via Benzinga
    News headline image
    My Top Vanguard Index ETF Pick for 2026 ↗
    Via The Motley Fool
    Topics ETFs Economy Stocks

    Frequently Asked Questions

    Is United Therapeutics Corporation - Common Stock publicly traded?
    Yes, United Therapeutics Corporation - Common Stock is publicly traded.
    What exchange does United Therapeutics Corporation - Common Stock trade on?
    United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for United Therapeutics Corporation - Common Stock?
    The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
    What is the current price of United Therapeutics Corporation - Common Stock?
    The current price of United Therapeutics Corporation - Common Stock is 479.79
    When was United Therapeutics Corporation - Common Stock last traded?
    The last trade of United Therapeutics Corporation - Common Stock was at 02/04/26 11:57 AM ET
    What is the market capitalization of United Therapeutics Corporation - Common Stock?
    The market capitalization of United Therapeutics Corporation - Common Stock is 21.54B
    How many shares of United Therapeutics Corporation - Common Stock are outstanding?
    United Therapeutics Corporation - Common Stock has 22B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.